The four and a half lim family members are novel interactants of the human T-cell leukemia virus type 1 tax oncoprotein

Journal of Virology

Volumn 87, Issue 13, 2013, Pages 7435-7444

  McCabe, Áine ^a   Hashimoto, Kenichi ^b   Hall, William W ^a   Sheehy, Noreen ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIM PROTEIN; PROTEIN FHL1; PROTEIN FHL2; PROTEIN FHL3; TAX PROTEIN; TAX1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SPREADING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; VIRUS PATHOGENESIS;

ANIMALS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CHROMATIN IMMUNOPRECIPITATION; COS CELLS; CYTOSKELETON; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, T-CELL; LIM DOMAIN PROTEINS; NEOPLASM PROTEINS; PLASMIDS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84880373012     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00070-13     Document Type: Article

References (58)

1. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U. 1992. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:4570-4575.
2. Matsuoka M. 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22:5131-5140.
3. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76.
4. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC. 2012. Host-pathogen interactome mapping for HTLV-1 and 2 retroviruses. Retrovirology 9:26.
5. Sodroski J. 1992. The human T-cell leukemia virus (HTLV) transactivator (Tax) protein. Biochim. Biophys Acta 1114:19-29.
6. Hiscott J, Petropoulos L, Lacoste J. 1995. Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex. Virology 214:3-11.
7. Giebler HA, Loring JE, van Orden K, Colgin MA, Garrus JE, Escudero KW, Brauweiler A, Nyborg JK. 1997. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol. Cell. Biol. 17:5156-5164.
8. Lenzmeier BA, Giebler HA, Nyborg JK. 1998. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol. 18:721-731.
9. Wessner R, Tillmann-Bogush M, Wigdahl B. 1995. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer. J. Neurovirol. 1:62-77.
10. Zhao LJ, Giam CZ. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. U.S.A. 89:7070-7074.
11. Peloponese JM, Yeung ML, Jeang KT. 2006. Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol. Res. 34:1-12.
12. Sheehy N, Lillis L, Watters K, Lewis M, Gautier V, Hall W. 2006. Functional analysis of human T lymphotropic virus type 2 Tax proteins. Retrovirology 3:20.
13. Iha H, Peloponese JM, Verstrepen L, Zapart G, Ikeda F, Smith CD, Starost MF, Yedavalli V, Heyninck K, Dikic I, Beyaert R, Jeang KT. 2008. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J. 27:629-641.
14. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW. 2007. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 81:13735-13742.
15. Kadrmas JL, Beckerle MC. 2004. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5:920-931.
16. Chan KK, Tsui SK, Ngai SM, Lee SM, Kotaka M, Waye MM, Lee CY, Fung KP. 2000. Protein-protein interaction of FHL2, a LIM domain protein protein preferentially expressed in human heart, with hCDC47. J. Cell. Biochem. 76:499-508.
17. Coghill ID, Brown S, Cottle DL, McGrath MJ, Robinson PA, Nandurkar HH, Dyson JM, Mitchell CA. 2003. FHL3 is an actin-binding protein that regulates alpha-actinin-mediated actin bundling: FHL3 localizes to actin stress fibers and enhances cell spreading and stress fiber disassembly. J. Biol. Chem. 278:24139-24152.
18. Dye BT, Patton JG. 2001. An RNA recognition motif (RRM) is required for the localization of PTB-associated splicing factor (PSF) to subnuclear speckles. Exp. Cell Res. 263:131-144.
19. Fimia GM, De Cesare D, Sassone-Corsi P. 2000. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol. Cell. Biol. 20:8613-8622.
20. Hill AA, Riley PR. 2004. Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2. Mol. Cell. Biol. 24:9835-9847.
21. Lange S, Auerbach D, McLoughlin P, Perriard E, Schafer BW, Perriard JC, Ehler E. 2002. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 115:4925-4936.
22. Martin B, Schneider R, Janetzky S, Waibler Z, Pandur P, Kuhl M, Behrens J, von der Mark K, Starzinski-Powitz A, Wixler V. 2002. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J. Cell Biol. 159:113-122.
23. Muller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schule R. 2000. FHL2, a novel tissuespecific coactivator of the androgen receptor. EMBO J. 19:359-369.
24. Samson T, Smyth N, Janetzky S, Wendler O, Muller JM, Schule R, von der Mark H, von der Mark K, Wixler V. 2004. The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor. J. Biol. Chem. 279:28641-28652.
25. Shen Y, Jia Z, Nagele RG, Ichikawa H, Goldberg GS. 2006. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res. 66:1543-1552.
26. Johannessen M, Moller S, Hansen T, Moens U, Van Ghelue M. 2006. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 63:268-284.
27. Niu C, Yan Z, Cheng L, Zhu J, Zhang H, Xu X, Lin J, Ye Q. 2011. Downregulation and antiproliferative role of fhl3 in breast cancer. IUBMB Life 63:764-771.
28. Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu W, Zhu J, Han J, Zhang H, Lin J, Cheng L, Qin X, Niu C, Yuan B, Wang X, Zhu C, Zhou Y, Li J, Song H, Huang C, Ye Q. 2009. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J. Clin. Invest. 119:349-361.
29. Li HY, Ng EK, Lee SM, Kotaka M, Tsui SK, Lee CY, Fung KP, Waye MM. 2001. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET). J. Cell. Biochem. 80:293-303.
30. Robinson PA, Brown S, McGrath MJ, Coghill ID, Gurung R, Mitchell CA. 2003. Skeletal muscle LIM protein 1 regulates integrin-mediated myoblast adhesion, spreading, and migration. Am. J. Physiol. Cell Physiol. 284:C681-C695.
31. Wixler V, Hirner S, Muller JM, Gullotti L, Will C, Kirfel J, Gunther T, Schneider H, Bosserhoff A, Schorle H, Park J, Schule R, Buettner R. 2007. Deficiency in the LIM-only protein Fhl2 impairs skin wound healing. J. Cell Biol. 177:163-172.
32. Cottle DL, McGrath MJ, Cowling BS, Coghill ID, Brown S, Mitchell CA. 2007. FHL3 binds MyoD and negatively regulates myotube formation. J. Cell Sci. 120:1423-1435.
33. Morlon A, Sassone-Corsi P. 2003. The LIM-only protein FHL2 is a serum- inducible transcriptional coactivator of AP-1. Proc. Natl. Acad. Sci. U.S.A. 100:3977-3982.
34. Tsuji T, Sheehy N, Gautier VW, Hayakawa H, Sawa H, Hall WW. 2007. The nuclear import of the human T lymphotropic virus type I (HTLV-1) tax protein is carrier-and energy-independent. J. Biol. Chem. 282:13875-13883.
35. Lewis MJ, Sheehy N, Salemi M, VanDamme AM, Hall WW. 2002. Comparison of CREB-and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins. Virology 295:182-189.
36. Zhao LJ, Giam CZ. 1991. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc. Natl. Acad. Sci. U.S.A. 88:11445-11449.
37. Miyatake Y, Oliveira AL, Jarboui MA, Ota S, Tomaru U, Teshima T, Hall WW, Kasahara M. 2013. Protective roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells. Am. J. Pathol. 182: 1832-1842.
38. Endo K, Hirata A, Iwai K, Sakurai M, Fukushi M, Oie M, Higuchi M, Hall WW, Gejyo F, Fujii M. 2002. Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J. Virol. 76:2648-2653.
39. Kashanchi F, Brady JN. 2005. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24:5938-5951.
40. Burton M, Upadhyaya CD, Maier B, Hope TJ, Semmes OJ. 2000. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets. J. Virol. 74:2351-2364.
41. Morgan MJ, Madgwick AJ. 1999. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle. Biochem. Biophys. Res. Commun. 255:245-250.
42. Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M. 2008. Clinical significance of loss of Fhl1 expression in human gastric cancer. Ann. Surg. Oncol. 15:2293-2300.
43. Yan P, Fu J, Qu Z, Li S, Tanaka T, Grusby MJ, Xiao G. 2009. PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood 113:4370-4380.
44. Fu J, Yan P, Li S, Qu Z, Xiao G. 2010. Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis. Oncogene 29:6499-6507.
45. Semmes OJ, Jeang KT. 1992. HTLV-I Tax is a zinc-binding protein: role of zinc in Tax structure and function. Virology 188:754-764.
46. Adya N, Giam CZ. 1995. Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors. J. Virol. 69:1834-1841.
47. Bantignies F, Rousset R, Desbois C, Jalinot P. 1996. Genetic characterization of transactivation of the human T-cell leukemia virus type 1 promoter: Binding of Tax to Tax-responsive element 1 is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors. Mol. Cell. Biol. 16:2174-2182.
48. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A. 1995. Mechanism of DNA-binding enhancement enhancement by the human T-cell leukaemia virus transactivator Tax. Nature 376:606-608.
49. Bex F, Yin MJ, Burny A, Gaynor RB. 1998. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol. Cell. Biol. 18:2392-2405.
50. Ku SC, Lee J, Lau J, Gurumurthy M, Ng R, Lwa SH, Klase Z, Kashanchi F, Chao SH. 2008. XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription. J. Virol. 82:4343-4353.
51. Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, Barbeau B, Nyborg JK, Mesnard JM. 2007. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 81: 1543-1553.
52. Turner J, Nicholas H, Bishop D, Matthews JM, Crossley M. 2003. The LIM protein FHL3 binds basic Kruppel-like factor/Kruppel-like factor 3 and its co-repressor C-terminal-binding protein 2. J. Biol. Chem. 278: 12786-12795.
53. Gatza ML, Marriott SJ. 2006. Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism. J. Virol. 80:6657-6668.
54. Legros S, Boxus M, Gatot JS, Van Lint C, Kruys V, Kettmann R, Twizere JC, Dequiedt F. 2011. The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6. Oncogene 30:4050-4062.
55. Gatza ML, Dayaram T, Marriott SJ. 2007. Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export. Retrovirology 4:95.
56. Pique C, Jones KS. 2012. Pathways of cell-cell transmission of HTLV-1. Front. Microbiol. 3:378.
57. Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y, Okayama A, Hamada K, Okabe H, Murakami Y, Tsubouchi H, Morishita K. 2005. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105:1204-1213.
58. Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O'Garra A, Taylor GP, Bangham CR. 2012. Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 8:e1002480. doi:10.1371/journal.ppat.1002480.